Properties
Description
ZLN024 downregulates metabolic and energy homeostasis pathways, affecting cellular energy balance and potentially influencing cancer and metabolic disorders. It targets AMPK α1β1γ1, AMPK α2β1γ1, and AMPK α2β1γ1.
Molecular Formula
C13H13BrN2OS
Targets
AMPK α1β1γ1: 0.42 μM (EC50); AMPK α2β1γ1: 0.95 μM (EC50); AMPK α2β1γ1: 0.13 μM (EC50)
Identity
Confirmed by NMR/HPLC/MS.
Applications
ZLN024 is applied in studies on its ability to activate AMPK and its effects in metabolic and cardiovascular diseases.